BioStock: BiBBInstruments aims to revolutionise pancreatic cancer diagnostics

Currently, pancreatic cancer is too often detected in its late stages, significantly contributing to the high mortality rate. Medtech company BiBBInstruments is developing the world's first CE-marked electric driven ultrasound-guided endoscopic biopsy instrument, EndoDrill. The device could become a useful tool in diagnosing pancreatic cancer earlier in the course of the disease. CEO Fredrik Lindblad spoke to BioStock about the device and its potential within this indication.

Read the interview with BiBBInstruments' CEO Fredrik Lindblad at biostock.se:

https://www.biostock.se/en/2023/03/bibbinstruments-aims-to-revolutionise-pancreatic-cancer-diagnostics

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/